Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Clearside Biomedical, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +2 vs. Q3 2023
- Shares held
- 7.75M
- −91.8K (−1.2%) vs. Q3 2023
- Total value
- $9.06M
- +$2.24M (+32.9%) vs. Q3 2023
- New holders
- 9
- 10 more added
- Sold out
- 7
- 10 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLSD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.26K |
| Q1 2026 | 1 | $7.87K |
| Q4 2025 | 1 | $19.1K |
| Q3 2025 | 26 | $2.18M |
| Q2 2025 | 45 | $7.51M |
| Q1 2025 | 44 | $8.09M |
| Q4 2024 | 44 | $8.97M |
| Q3 2024 | 49 | $12.7M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 52 | $23.8M |
| Q4 2023 | 48 | $9.06M |
| Q3 2023 | 46 | $6.82M |
| Q2 2023 | 54 | $9.62M |
| Q1 2023 | 51 | $9.09M |
| Q4 2022 | 53 | $10.2M |
| Q3 2022 | 54 | $13.6M |
| Q2 2022 | 53 | $20.1M |
| Q1 2022 | 60 | $37.5M |
| Q4 2021 | 67 | $57.8M |
| Q3 2021 | 66 | $121.5M |
| Q2 2021 | 53 | $95.8M |
| Q1 2021 | 52 | $43.8M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Clearside Biomedical, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,176,316 | $2.55M | 0.00% | +9,431+0.4% | Added |
| Carmignac Gestion | 2,132,744 | $2.50M | 0.04% | 00.0% | Unchanged |
| BlackRock Inc. | 759,743 | $888.9K | 0.00% | −3,489−0.5% | Reduced |
| Geode Capital Management, LLC | 490,690 | $574.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 384,689 | $450.0K | 0.00% | +111,400+40.8% | Added |
| State Street Corp | 193,363 | $226.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 175,600 | $205.5K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 175,000 | $204.8K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 169,629 | $198.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 144,434 | $169.0K | 0.00% | −23,338−13.9% | Reduced |
| Brown Wealth Management, LLC | 110,000 | $128.7K | 0.06% | 00.0% | Unchanged |
| Northeast Financial Consultants Inc | 93,000 | $108.8K | 0.01% | +10,000+12.0% | Added |
| Northern Trust Corp | 91,777 | $107.4K | 0.00% | −3,006−3.2% | Reduced |
| Susquehanna International Group, LLP | 90,093 | $105.4K | 0.00% | +31,091+52.7% | Added |
| Synovus Financial Corp | 53,071 | $62.1K | 0.00% | −5,000−8.6% | Reduced |
| Captrust Financial Advisors | 50,000 | $58.5K | 0.00% | 00.0% | Unchanged |
| Natixis | 47,500 | $55.6K | 0.00% | +47,500 | New |
| Citadel Advisors LLC | 45,838 | $53.6K | 0.00% | +26,090+132.1% | Added |
| Banque Cantonale Vaudoise | 40,000 | $47.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 34,044 | $39.8K | 0.00% | −19,500−36.4% | Reduced |
| Millennium Management LLC | 33,638 | $39.4K | 0.00% | +33,638 | New |
| Bank of New York Mellon Corp | 29,519 | $34.5K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 28,023 | $32.8K | 0.01% | +28,023 | New |
| Curi Capital | 25,000 | $29.3K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 20,216 | $23.7K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 20,000 | $23.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 19,168 | $22.4K | 0.00% | −8,377−30.4% | Reduced |
| Mariner, LLC | 18,950 | $22.2K | 0.00% | +18,950 | New |
| Virtu Financial LLC | 17,513 | $20.0K | 0.00% | +17,513 | New |
| Tower Research Capital LLC (TRC) | 14,012 | $16.4K | 0.00% | +3,176+29.3% | Added |
| Stratos Wealth Advisors, LLC | 14,000 | $16.4K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 11,490 | $13.0K | 0.00% | +6,641+137.0% | Added |
| Steward Partners Investment Advisory, LLC | 11,000 | $12.9K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 10,500 | $12.0K | 0.00% | −6,000−36.4% | Reduced |
| The PNC Financial Services Group, Inc. | 5,586 | $6.54K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,209 | $3.75K | 0.00% | +27+0.8% | Added |
| Cutler Group LP | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,126 | $1.32K | 0.00% | +33+3.0% | Added |
| Rhumbline Advisers | 1,092 | $1.28K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $1.17K | 0.00% | −1,000−50.0% | Reduced |
| Huntington National Bank | 500 | $585 | 0.00% | +500 | New |
| Wells Fargo & Company | 465 | $545 | 0.00% | +24+5.4% | Added |
| Scarborough Advisors, LLC | 277 | $324 | 0.00% | +277 | New |
| Creative Financial Designs Inc | 100 | $117 | 0.00% | +100 | New |
| Qube Research & Technologies Ltd | 4 | $5 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 2 | $2 | 0.00% | −210−99.1% | Reduced |
| Royal Bank of Canada | 225 | $0 | 0.00% | −44,801−99.5% | Reduced |
| Householder Group Estate & Retirement Specialist, LLC | 385 | $0 | 0.00% | +385 | New |
| Water Island Capital LLC | 0 | $0 | 0.00% | −82,500−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −71,776−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −62,900−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −54,177−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −31,442−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −17,536−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,587−100.0% | Sold out |